SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000891554-01-503447
Filing Date
2001-07-12
Accepted
2001-07-12 00:00:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d26243_sc13d.txt SC 13D 19223
2 PURCHASE AGREEMENT d26243_ex1.txt EX-1 43203
3 REGISTRATION RIGHTS AGREEMENT d26243_ex2.txt EX-2 58458
4 VOTING AGREEMENT d26243_ex3.txt EX-3 21848
  Complete submission text file 0000891554-01-503447.txt   145172
Mailing Address
Business Address 500 ARCOLA RD P O BOX 1200 M/S 5B14 COLLEGEVILLE PA 19426-0107 6104548000
RHONE POULENC RORER INC (Filed by) CIK: 0000217028 (see all company filings)

IRS No.: 231699163 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Subject) CIK: 0001018710 (see all company filings)

IRS No.: 742704230 | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-61001 | Film No.: 1680171
SIC: 2834 Pharmaceutical Preparations